ArticlePloS one2013

Alternative signaling pathways as potential therapeutic targets for overcoming EGFR and c-Met inhibitor resistance in non-small cell lung cancer.

Jason T Fong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.